- Home
- EMA vs FMS Comparison
EMA vs FMS Comparison
Compare EMA & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMA
- FMS
- Stock Information
- Founded
- EMA 1998
- FMS 1996
- Country
- EMA Canada
- FMS Germany
- Employees
- EMA N/A
- FMS N/A
- Industry
- EMA Electric Utilities: Central
- FMS Misc Health and Biotechnology Services
- Sector
- EMA Utilities
- FMS Health Care
- Exchange
- EMA Nasdaq
- FMS Nasdaq
- Market Cap
- EMA 14.3B
- FMS 14.1B
- IPO Year
- EMA N/A
- FMS 1996
- Fundamental
- Price
- EMA $47.98
- FMS $23.40
- Analyst Decision
- EMA
- FMS Sell
- Analyst Count
- EMA 0
- FMS 2
- Target Price
- EMA N/A
- FMS $30.00
- AVG Volume (30 Days)
- EMA 160.4K
- FMS 486.5K
- Earning Date
- EMA 11-07-2025
- FMS 11-04-2025
- Dividend Yield
- EMA 4.34%
- FMS 2.44%
- EPS Growth
- EMA 67.89
- FMS 8.40
- EPS
- EMA 2.65
- FMS 2.86
- Revenue
- EMA $6,126,111,896.00
- FMS $23,046,819,198.00
- Revenue This Year
- EMA $22.22
- FMS $1.75
- Revenue Next Year
- EMA N/A
- FMS $3.01
- P/E Ratio
- EMA $18.24
- FMS $16.08
- Revenue Growth
- EMA 15.17
- FMS 2.10
- 52 Week Low
- EMA $43.90
- FMS $21.32
- 52 Week High
- EMA $49.77
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- EMA 48.40
- FMS 26.24
- Support Level
- EMA $47.37
- FMS $23.61
- Resistance Level
- EMA $48.61
- FMS $24.17
- Average True Range (ATR)
- EMA 0.64
- FMS 0.40
- MACD
- EMA -0.05
- FMS -0.29
- Stochastic Oscillator
- EMA 46.73
- FMS 0.79
About EMA Emera Incorporated Common Shares
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.